Skip to main content
OpenTrials
Completed

NCT Number: NCT01545115

Study of the Environmental Factors Modulating Children Immune Response in Northern Senegal

Longitudinal survey in Northern Senegal to investigate the environmental factors modulating the immune response to childhood vaccines and to malaria.

A cohort of 410 children aged 1 to 10 from 5 villages of the Senegal River Valley(Podor District) was followed-up for 18 months. During that period, 5 visits have been made to the villages to assess the immunological and nutritional status of the children.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Longitudinal survey in Northern Senegal to investigate the environmental factors modulating the immune response to childhood vaccines and to malaria.

A cohort of 410 children aged 1 to 10 from 5 villages of the Senegal River Valley(Podor District) was followed-up for 18 months. During that period, 5 visits have been made to the villages to assess the immunological and nutritional status of the children (T1 (October 2008), T2 (January 2009), T3 (June 2009), T4 (October 2009) and T5 (January 2010)).

The project was approved by the National Ethics Committee of Senegal. Written individual informed consent was obtained from each participant's parent or legal guardian at the beginning of the survey, and at each visit child's and parent's approval was sought orally.

Capillary blood was collected from the finger tip of each child, using sterile single-use material.

Body temperature was measured by means of auricular thermometer at all visits. Anthropomorphic data were collected at visits T2, T3, T4 and T5.

A Hemocue photometer (HemoCue AB, Ängelholm, Sweden) was used to determine haemoglobin concentration on a blood drop at visits T3, T4 and T5.

At each visit, a questionnaire was filled in for every child. Information was collected on the date of birth family membership to asses if siblings or children living in the same house were in the cohort.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: between 1 and 10 years

Exclusion criteria

  • Fever (body temperature superior to 38.5 °C)

Sponsors and collaborators

Lead sponsor

Biomedical Research Center EPLS

Other

Collaborators

  • Centre National de la Recherche Scientifique, France
  • Centre d'Infection et d'Immunité de Lille
  • Institut National de la Santé Et de la Recherche Médicale, France
  • Institut Pasteur de Lille
  • Institut de Recherche pour le Developpement
  • Institut de Recherche pour le Developpement, Senegal
  • Région Nord-Pas de Calais, France
  • University of Lille Nord de France

Registry information

Acronym: AnoPalAnoVac

Important dates

Study start
2008
Primary completion
2010
Study completion
2010
First posted
Mar 6, 2012
Registry last updated
Mar 13, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.